Targeting the ubiquitin-proteasome system to activate wild-type p53 for cancer therapy

被引：37

作者：

Allende-Vega, Nerea ^{[1
]}

Saville, Mark K. ^{[1
]}

机构：

[1] Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg & Mol Oncol, CR UK Cell Transformat Res Grp, Dundee DD1 9SY, Scotland

来源：

SEMINARS IN CANCER BIOLOGY | 2010年 / 20卷 / 01期

关键词：

Ubiquitin; P53; Mdm2; MdmX; 26S proteasome; E1; E2; E3; Deubiquitinating enzyme; SMALL-MOLECULE INHIBITORS; EARLY EMBRYONIC LETHALITY; TUMOR-SUPPRESSOR PROTEIN; CELL-CYCLE ARREST; IN-VIVO; DNA-DAMAGE; LIGASE ACTIVITY; PROSTATE-CANCER; MDM2; PROMOTES; COLON-CANCER;

D O I：

10.1016/j.semcancer.2009.10.004

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Ubiquitination plays a key role in regulating the tumour suppressor p53. It targets p53 for degradation by the 26S proteasome. The ubiquitin pathway also regulates the activity and localisation of p53. Ubiquitination requires ubiquitin-activating and -conjugating enzymes and ubiquitin ligases. In addition, ubiquitination can be reversed by the action of deubiquitinating enzymes. Here we give an overview of the role of components of the ubiquitin-proteasome system in the regulation of p53 and review progress in targeting these proteins to activate wild-type p53 for the treatment of cancer. (C) 2009 Published by Elsevier Ltd.

引用

页码：29 / 39

页数：11

共 50 条

[1] Targeting the ubiquitin-proteasome system for cancer therapy
Yang, Yili
Kitagaki, Jirouta
Wang, Honghe
Hou, De-Xing
Perantoni, Alan O.
[J]. CANCER SCIENCE, 2009, 100 (01) : 24 - 28
[2] Targeting the ubiquitin-proteasome system for cancer therapy
Shen, Min
Schmitt, Sara
Buac, Daniela
Dou, Q. Ping
[J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (09) : 1091 - 1108
[3] Flavonoids activate wild-type p53
Plaumann, B
Fritsche, M
Rimpler, H
Brandner, G
Hess, RD
[J]. ONCOGENE, 1996, 13 (08) : 1605 - 1614
[4] Targeting the Ubiquitin-Mediated Proteasome Degradation of p53 for Cancer Therapy
DeVine, Tiffany
Dai, Mu-Shui
[J]. CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (18) : 3248 - 3262
[5] The Small Molecules Targeting Ubiquitin-Proteasome System for Cancer Therapy
Ao, Nannan
Chen, Qianping
Liu, Geng
[J]. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2017, 20 (05) : 403 - 413
[6] Targeting Ubiquitin-Proteasome System With Copper Complexes for Cancer Therapy
Chen, Xin
Dou, Q. Ping
Liu, Jinbao
Tang, Daolin
[J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
[7] Targeting the Ubiquitin-Proteasome System and Recent Advances in Cancer Therapy
Spano, Daniela
Catara, Giuliana
[J]. CELLS, 2024, 13 (01)
[8] Targeting the ubiquitin-proteasome pathway in cancer therapy
Ishii, Yuki
Waxman, Samuel
Germain, Doris
[J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2007, 7 (03) : 359 - 365
[9] The ubiquitin-proteasome system is inhibited by p53 protein expression in human ovarian cancer cells
Hwang, In Young
Baguley, Bruce C.
Ching, Lai-Ming
Gilchrist, Catherine A.
[J]. CANCER LETTERS, 2010, 294 (01) : 82 - 90
[10] Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer
Zhang, Shengliang
Carlsen, Lindsey
Hernandez Borrero, Liz
Seyhan, Attila A.
Tian, Xiaobing
El-Deiry, Wafik S.
[J]. BIOMOLECULES, 2022, 12 (04)

← 1 2 3 4 5 →